NCT07514533 clinical trial report covering Pucotenlimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07514169 clinical trial report covering Polatuzumab Vedotin-Piiq, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07515014 clinical trial report covering E-6742, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07514793 clinical trial report covering Iparomlimab/Tuvonralimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07514832 clinical trial report covering Venetoclax, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07515625 clinical trial report covering Sintilimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07515820 clinical trial report covering SHR-3821, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07515469 clinical trial report covering Iparomlimab/Tuvonralimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07514767 clinical trial report covering Nivolumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07514338 clinical trial report covering Napazimone, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07515963 clinical trial report covering Irinotecan Hydrochloride Lioposome, Phase 2, endpoints, sponsor, geography, readout timing and development white

NCT07514858 clinical trial report covering Lu-AF28996, Phase 2, endpoints, sponsor, geography, readout timing and development white space.